Information Provided By: 
Fly News Breaks for June 27, 2016
HLS
Jun 27, 2016 | 05:43 EDT
Barclays analyst Joshua Raskin downgraded HealthSouth to Underweight saying the risk/reward has "moved negatively" following the recent appreciation in the shares. The analyst notes that HealthSouth's leverage is up substantially over the past one and a half years. He lowered his price target for the shares to $42 from $45.
News For HLS From the Last 2 Days
There are no results for your query HLS
